WELL Health Technologies Corp. (TSX:WELL)
Canada flag Canada · Delayed Price · Currency is CAD
4.320
+0.010 (0.23%)
Sep 24, 2026, 4:00 PM EST

WELL Health Technologies Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, WELL Health Technologies stock has a consensus rating of "Strong Buy" and an average price target of $7.27. The average 1-year stock price forecast is 68.29% higher than the current stock price, while the lowest is $5.00 (+15.74%) and the highest is $8.50 (+96.76%).

Price Target: $7.27 (+68.29%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$7.27$7.25$8.50
Change+15.74%+68.29%+67.82%+96.76%

Analyst Ratings

The average analyst rating for WELL Health Technologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy778888
Buy666555
Hold000000
Sell000000
Strong Sell000000
Total131314131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$8.50
BuyMaintains$8.50+96.76%Sep 23, 2026
Unknown Analyst
TD Cowen
No rating
TD Cowen
Buy
Maintains
$7.00
BuyMaintains$7.00+62.04%Sep 14, 2026
Maxim Group
Maxim Group
Buy
Reiterates
$7.00
BuyReiterates$7.00+62.04%Aug 11, 2026
Raymond James
Raymond James
Buy
Maintains
n/a
BuyMaintainsn/an/aAug 7, 2026
CIBC
CIBC
Buy
Reiterates
$5.50 → $6.00
BuyReiterates$5.50 → $6.00+38.89%Jun 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.60B
from 1.40B
Increased by 14.41%
Revenue Next Year
1.72B
from 1.60B
Increased by 7.59%
EPS This Year
0.25
from 0.49
Decreased by -48.44%
EPS Next Year
0.37
from 0.25
Increased by 45.82%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
302.32M569.14M776.05M919.69M1.40B1.60B
Revenue Growth
501.76%88.25%36.36%18.51%52.25%14.41%
Gross Profit
153.70M303.29M372.27M363.01M618.84M703.82M
Gross Margin
50.84%53.29%47.97%39.47%44.20%43.94%
Operating Income
1.46M33.08M34.52M-29.86M93.59M59.63M
Net Income
-44.18M1.37M82.00K32.61M-7.36M-29.59M
EPS
----0.490.25
EPS Growth
----1,533.33%-48.44%
Forward PE
196.02196.02196.02226.4041.9617.10
Free Cash Flow
----94.02M78.68M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue202620272028
High1.6B
Avg1.6B
Low1.6B

Revenue Growth

Revenue Growth202620272028
High
15.4%
Avg
14.4%
Low
13.1%

EPS Forecast

EPS202620272028
High0.31
Avg0.25
Low0.16

EPS Growth

EPS Growth202620272028
High
-36.7%
Avg
-48.4%
Low
-67.3%